Financial statements Medgenetics

Balance sheet of Medgenetics

Company age:
Age:
12 y. 9 m. 20 d.
Share capital:
Share capital:
10 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of MEDGENETICS

Year
2018
2019
2020
2021
Total assets 1 694 326,00 1 694 519,52 2 537 580,84 2 131 792,54
A. Fixed assets 1 687 050,00 1 687 050,00 2 333 741,51 1 687 050,00
B. Current assets 7 276,00 7 469,52 203 839,33 444 742,54
C. Share capital contributions (basic funds) - - - 0,00
D. Own shares (stocks) - - - 0,00
Total liabilities 1 694 326,00 1 694 519,52 2 537 580,84 2 131 792,54
A. Equity 1 677 661,54 1 673 718,41 1 825 372,31 2 026 628,84
B. Liabilities and provisions for liabilities 16 664,46 20 801,11 712 208,53 105 163,70
I. Long-term liabilities - - 572 039,61 0,00
II. Short-term liabilities 16 664,46 20 801,11 140 168,92 105 163,70
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.